Cancer Genetics, Inc.

A Leader in Precision Medicine and Drug Discovery Services

Recognized as a leader in drug discovery, preclinical oncology, and immuno-oncology services, Cancer Genetics, Inc. (CGI) is committed to enhancing the development of advanced therapies in precision medicine.

About Our Company

Latest News

View All News
An Introduction to FHACT®

An Introduction to FHACT®

Our FISH-based HPV-associated Cancer Test

At CGI, we have developed an innovative DNA-Fluorescent in situ hybridization (FISH) probe panels to help clinicians in the clinical management and detection of HPV-associated precancer and cancers.

More About FHACT

Meet the CGI Team

Our team of world-class scientists and experienced management is helping empower precision medicine.

View Management Team View Board of Directors
Our Media

Our Media

View our latest press releases, videos, events, and articles in our media collection.

View Media
Excellence in Oncology

Excellence in Oncology

Our comprehensive array of integrated laboratory services adds significant value to oncology patients.

About Clinical Testing
Email Alerts

Email Alerts

Stay informed and receive company updates straight to your inbox.

Sign Up Today